CoreCap Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63K Buy
26
+16
+160% +$1.66K ﹤0.01% 2469
2026
Q1
$967 Hold
10
﹤0.01% 2541
2025
Q4
$1.06K Hold
10
﹤0.01% 2590
2025
Q3
$1.27K Hold
10
﹤0.01% 2444
2025
Q2
$1.23K Sell
10
-56
-85% -$6.4K ﹤0.01% 2396
2025
Q1
$6.68K Hold
66
﹤0.01% 1992
2024
Q4
$6.09K Sell
66
-2
-3% -$196 ﹤0.01% 1927
2024
Q3
$6.57K Sell
68
-297
-81% -$26.7K ﹤0.01% 1909
2024
Q2
$31.3K Buy
365
+58
+19% +$4.87K ﹤0.01% 773
2024
Q1
$25.4K Buy
+307
New +$22.5K ﹤0.01% 1372

Other funds holding EHC

CoreCap Advisors's EHC Position: Q2 2026 in Review

CoreCap Advisors increased its Encompass Health (EHC) stake by 160% in Q2 2026, buying an estimated $1.66K and bringing the position to 26 shares worth $2.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

CoreCap Advisors first reported a position in EHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $31.3K in Q2 2024. 57 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • CoreCap Advisors held 26 shares of Encompass Health worth $2.63K as of Q2 2026.
  • CoreCap Advisors bought 16 Encompass Health shares in Q2 2026, an estimated $1.66K.
  • Encompass Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2469 holding.
  • CoreCap Advisors first reported a position in Encompass Health in Q1 2024 and has held it in 10 quarters since.
  • CoreCap Advisors's Encompass Health position peaked at $31.3K in Q2 2024.
  • 57 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.